Financial News
A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots
September 17, 2021 at 06:00 AM EDT
A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech's application to offer booster shots to the general public.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
